Published on in Vol 8, No 3 (2022): Jul-Sep
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/39068, first published
.
Journals
- Midha S, Hartley-Brown M, Mo C, Hossain S, Nadeem O, O’Donnell E, Bianchi G, Sperling A, Laubach J, Richardson P. A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma. Expert Opinion on Drug Safety 2023;22(11):1049 View
- Hansen D, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, Liu Y, Huo J. Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective. Journal of Patient Experience 2023;10 View
- Peña C, Graffigna P, Russo M, Forray E, Bustamante P. Improved overall survival of transplant eligible newly diagnosed multiple myeloma patients in a Chilean public center. How did we achieve it?. Hematology, Transfusion and Cell Therapy 2024;46(4):575 View
- Cerejo C. The untold emotional toll of navigating the health system: the journey of patients in/from India, living with serious and/or chronic conditions. Current Medical Research and Opinion 2024;40(9):1605 View
- Dwyer Orr L, Lin D, Wu B, LeBlanc T, Faiman B, Ahlstrom J, Yung M, Deering K, Kulbokas V, Feldman J, Kline E, Biran N. Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma. Patient Preference and Adherence 2024;Volume 18:2147 View